Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

5 February 2019

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Cate today joined MIA Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, and CEO Matthew Browne on a tour of Melanoma Institute Australia in Sydney. Cate also met young mum Jenny Day and her three little girls who lost their dad and husband David to melanoma. They are one of four families bravely sharing their stories of loss for the 2019 Melanoma March campaign.

Melanoma Institute Australia CEO Matthew Browne says the organisation is delighted to have Cate Campbell onboard as the 26-year-old athlete’s own recent brush with melanoma compellingly demonstrates the importance of being sun-safe and aware of changes to your skin.

Cate embodies the Australian way of life and her love of the outdoors, be it swimming, hiking or kayaking, makes her an ideal National Ambassador for MIA,” Matthew said. “Many people don’t realise melanoma kills one Australian every five hours and is the most common cancer affecting 15 to 39 year olds. By having Cate onboard we will better be able to reach young Australians with sun-safety and skin awareness messages.

Cate went for a skin check in November 2018 after bumping into a friend who had a near miss with melanoma. Cate had a mole on her arm removed during the check, which turned out to be Stage I melanoma and required further surgery. It was her melanoma diagnosis that inspired her to become an advocate for the importance of sun safety and skin checks.

As Australians, we spend so much time in the sun and with melanoma the most common cancer in young Australians I want to make sure people know the importance of having skin checks,” said Cate. “As someone with pale, freckly skin, keeping up with freckles and sun spots is difficult, but my melanoma developed in a mole I had my whole life and on the surface it looked like nothing had changed. I shudder to think what would have happened had I not had that mole checked. It literally saved my life.”

Melanoma Institute Australia is leading global research efforts to find a cure for melanoma. Despite recent breakthroughs tripling life expectancy for many advanced melanoma patients, more research is needed into why some people just don’t respond, and also to determine how to tackle earlier stage disease.

To reach zero deaths from melanoma, we need to crack the riddle of so-called ‘super progressors’, like David Day, whose disease progresses rapidly despite these new treatments and they die within months” said Professor Georgina Long. “We also need to better understand how we can use these new treatments during earlier stage melanoma, to stop it spreading to vital organs in the first place,” added Professor Scolyer. Melanoma March raises money to enable such national collaborative research projects to find a cure for melanoma. This year there will be 23 family friendly Melanoma March events across the country, as well as the 2000km Jay’s Longest Melanoma March from Adelaide to Sydney.

"I will be joining the Melanoma March event in my home town of Brisbane as I know I was incredibly lucky, but for so many people diagnosed with melanoma this isn’t the case,” Cate said.

We need to keep encouraging Australians to prioritise sun safety and skin awareness as part of their health regime, and we need answers. To find those answers we need research, and that means raising much-needed research dollars through campaigns like Melanoma March.

Please join me in helping those Australians bravely battling for their lives, and supporting families like David Day’s who are left behind.”

For more information on how to register for a march near you or donate to Melanoma March, go to  www.melanomamarch.org.au

 

MIA takes centre stage at leading cancer conference
05 Jun 2019

MIA takes centre stage at leading cancer conference

Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma is treated .

International Clinical Trials Day 2019
20 May 2019

International Clinical Trials Day 2019

Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.

Emma Betts' legacy will live on
17 May 2019

Emma Betts' legacy will live on

“I’m the age Emma was when she passed away. It almost feels unfair, that she has to not be here for me to be able to do this. But I will use this opportunity to push as hard as I can to reach our collective goal of zero deaths from melanoma.”

Support PBS listing for three adjuvant treatments of resected Stage III melanoma
13 May 2019

Support PBS listing for three adjuvant treatments of resected Stage III melanoma

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

Support PBS listing for pembrolizumab
06 May 2019

Support PBS listing for pembrolizumab

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

How are the Premier's Awards helping cancer researchers?
02 May 2019

How are the Premier's Awards helping cancer researchers?

MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
19 Mar 2019

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects

Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.

Making a difference to many
15 Mar 2019

Making a difference to many

Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 Feb 2019

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March

Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Melanoma breakthrough paves way for personalised treatment for all cancer patients
14 Feb 2019

Melanoma breakthrough paves way for personalised treatment for all cancer patients

Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.

Melanoma March announces 2019 Principal Partner
07 Feb 2019

Melanoma March announces 2019 Principal Partner

Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
05 Feb 2019

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

MIA experts collaborate on groundbreaking research
16 Jan 2019

MIA experts collaborate on groundbreaking research

MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
20 Dec 2018

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA

MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.

Possible PBS listing for dabrafenib and trametinib
18 Dec 2018

Possible PBS listing for dabrafenib and trametinib

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.

Arden Anglican School wins SunSafe Ambassador competition
13 Dec 2018

Arden Anglican School wins SunSafe Ambassador competition

Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.

DON'T CLOUD THE SUN-SAFE MESSAGE
08 Dec 2018

DON'T CLOUD THE SUN-SAFE MESSAGE

Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.

Professor Georgina Long named as one of world's most highly cited researchers
04 Dec 2018

Professor Georgina Long named as one of world's most highly cited researchers

Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.

Aussies need to protect themselves from 'everyday' sun damage
01 Dec 2018

Aussies need to protect themselves from 'everyday' sun damage

‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
29 Nov 2018

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma

A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.